| |
Centre for Policy on Ageing | |
 | |
|
| Why would caregivers not want to treat their relative's Alzheimer's disease? | | Author(s) | Jason H T Karlawish, David J Casarett, Bryan D James |
| Journal title | Journal of the American Geriatrics Society, vol 51, no 10, October 2003 |
| Pages | pp 1391-1397 |
| Keywords | Dementia ; Family care ; Attitude ; Drugs ; Social surveys ; United States of America. |
| Annotation | 102 caregivers of patients with mild to severe AD registered at the University of Pennsylvania's Alzheimer's Disease Centre were interviewed at home regarding their willingness to use a risk-free AD-slowing medicine and a medicine with 3% annual risk of gastrointestinal bleeding. 17 of the caregivers did not want their relative to take a risk-free medicine that could slow AD. These caregivers were older, depressed, had relatives living in a nursing home, had relatives with more severe dementia, and rated their relatives' quality of life (QOL) poorly. 52 did not want their relative to take the other medicine, and were more likely to be non-white, have financial burden, and rate their relatives' QOL poorly. The results suggest that caregivers are generally willing to slow the progression of their relative's dementia, even into the severe stage of the disease, especially if it can be done without risk to the patient. Clinical trials and practice guidelines should recognise those factors influencing a caregiver's assessment of patient QOL and the willingness to use AD-slowing treatments. (RH). |
| Accession Number | CPA-031212206 A |
| Classmark | EA: P6:SJ: DP: LLD: 3F: 7T |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|